Navigation Links
Optimer Pharmaceuticals to Present at June 2009 Investor Conferences
Date:6/4/2009

two Phase 3 clinical trials for the treatment of travelers' diarrhea, a form of infectious diarrhea. Additional information can be found at http://www.optimerpharma.com.

    Contacts

    Optimer Pharmaceuticals, Inc.
    Christina Donaghy, Corporate Communications Manager
    John D. Prunty, Chief Financial Officer & VP Finance
    858-909-0736

    Porter Novelli Life Sciences
    Jason I. Spark, Vice President
    619-849-6005


'/>"/>
SOURCE Optimer Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
2. Optimer Pharmaceuticals Reports First Quarter 2009 Financial Results
3. Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference
4. Raptor Pharmaceuticals Doses First Patient in Phase 2b Clinical Trial of DR Cysteamine for Cystinosis
5. Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting
6. Valeant Pharmaceuticals Reports Encouraging Final Results With Taribavirin Phase IIb Study
7. OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
8. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
9. Angiotech Pharmaceuticals announces FDA approval of next-generation TAXUS(R) Liberte(R) Atom(TM) Stent system
10. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
11. OncoGenex Pharmaceuticals to Webcast ASCO Reception on May 30, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013 PathoGenetix, ... system for rapid bacterial strain typing, announced today ... the company as Vice President of Engineering. Dr. ... the company’s RESOLUTION™ Microbial Genotyping System . ... benchtop instrument, pathogen-specific assay kits, database and software, ...
(Date:6/18/2013)... ActiGraph, a leading provider of objective physical ... community, announced today that Dr. Victor KR Matsudo has ... Scientific Director of the Physical Fitness Research Center of ... at Gama Filho University and the Chairman of the ... of Health of São Paulo State, Brazil. , ...
(Date:6/18/2013)... June 18, 2013 NuView Life Sciences ... and in vitro diagnostic (IVD) biomarkers, today announced the ... urine screen in development for the early detection of ... in an oral presentation at the 2013 Annual Meeting ... (SNMMI) in Vancouver, Canada on Sunday, June 9th. ...
(Date:6/17/2013)... CAMBRIDGE, MA (PRWEB) June 17, 2013 ... (AQM) system in March that helps better monitor potentially ... Station. The microAnalyzer V2.0, which was developed by ... International Space Station. , Astronauts breathe air that is ... exposure to harmful compounds in the air, even in ...
Breaking Biology Technology:PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3Dr. Victor KR Matsudo Joins ActiGraph Scientific Advisory Board 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 2NuView Life Sciences Announces Presentation of Data for Novel Prostate and Bladder Cancer Molecular Diagnostic at SNMMI 3New Monitoring System Will Better Protect NASA Astronauts on ISS 2
... 21 Sequenom, Inc. (NASDAQ: SQNM ), a ... it will report financial results for the second quarter of ... August 4, 2011. A conference call hosted by ... members of senior management will take place on the same ...
... BioSciences, Inc. (Nasdaq: SGMO ) today announced that ... on Wednesday, July 27, 2011, after the market closes. The ... 5:00 p.m. ET, which will be open to the public ... will review the financial results and discuss other business matters. ...
... , Daval International announced the completion ... blind Phase II,Study, Treating Patients with Bladder Dysfunction ... clinical,measures and assessment scores recorded on patients who ... used to investigate safety,efficacy and response to treatment. ...
Cached Biology Technology:Sequenom, Inc. Announces Date of Second Quarter 2011 Financial Results and Conference Call 2Sangamo BioSciences Announces Second Quarter 2011 Conference Call and Webcast 2Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 2Daval International Announces Completion of Phase II Trial for the Treatment of Bladder Dysfunction With AIMSPRO® in Secondary Progressive Multiple Sclerosis 3
(Date:6/18/2013)... awarded $12.7 million to match nine academic research ... to explore new treatments for patients in eight ... and schizophrenia. The collaborative pilot initiative, called Discovering ... by the National Center for Advancing Translational Sciences ... , The process of developing a new therapeutic ...
(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...
(Date:6/17/2013)... new virus in patients with severe brain infections in ... virus is responsible for the symptoms of disease. , ... out of 644 patients with severe brain infections in ... any of the 122 patients with non-infectious brain disorders ... central nervous system are often fatal and patients who ...
Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4The secret of DNA methylation 2New virus isolated from patients with severe brain infections 2New virus isolated from patients with severe brain infections 3
... weed is another man,s wonder and University of Guam research ... his career finding environmentally safe methods to control invasive plants. ... and coauthor of the book Biological Control of Tropical ... the Cambridge University Press and available to the public in ...
... signs of climate change in the upper atmosphere and ... Tyler Prize for Environmental Achievement. The award, ... will go to Richard Alley, professor of geosciences at ... atmospheric and climate sciences in the Scripps Institution of ...
... release is available in French and Spanish ... more than 160 endorsed science projects assembled from researchers in ... covers a two-year period to March 2009 to allow for ... joint project of WMO and ICSU, IPY spearheaded efforts to ...
Cached Biology News:Winners of Tyler environmental prize announced 2Polar research reveals new evidence of global environmental change 2Polar research reveals new evidence of global environmental change 3
Request Info...
QML offers standard and customized paraffin embedded tissue blocks....
Use our experts and resources to develop reagent systems for your applications....
Request Info...
Biology Products: